-+ 0.00%
-+ 0.00%
-+ 0.00%
City Of Hope And Adagene Launch Phase 1 Clinical Trial To Explore Combination Therapy For Patients Battling Metastatic Colorectal Cancer
Share
Listen to the news

Study was designed by medical oncologist to accelerate lifesaving care to patients

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, and Adagene Inc. ("Adagene") (NASDAQ:ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today announced the launch of an innovative Phase 1 clinical trial to explore a new combination therapy for patients battling metastatic colorectal cancer, particularly for those whose disease has resisted standard treatments.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending